← All organizations

Milestone Pharmaceuticals Inc.

For profitWebsite ↗

Also known as: Milestone Pharmaceuticals Inc. | MILESTONE PHARMS USA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Dec 12, 2025

Timeline

2000s

Jan 1, 2003
Milestone Pharmaceuticals Inc.— Founded

2020s

Dec 12, 2025
etripamil— Marketing Organization

Drugs by trial phase (1 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

etripamil

Indications

Studied for

Marketed drugs (1)

etripamil

Recent trials (10)

NCT06716021Lead sponsorPhase 3Mar 31, 2025
NCT05763953Lead sponsorPhase 2Dec 11, 2023
NCT05511870CollaboratorPhase 1Mar 31, 2023
NCT05410860CollaboratorPhase 3Jun 30, 2022
NCT04952610Lead sponsorPhase 3Nov 30, 2021
NCT04467905Lead sponsorPhase 2Nov 19, 2020
NCT04072835Lead sponsorPhase 3Sep 2, 2019
NCT03635996Lead sponsorPhase 3Aug 31, 2019
NCT03464019Lead sponsorPhase 3Jun 18, 2018
NCT02296190Lead sponsorPhase 2Jan 1, 2015

Details

Founded: Montreal, CA Jan 1, 2003
Last known activity: Dec 12, 2025